Related Experiment Video
Updated: Jan 10, 2026

Investigating Long-Distance Transport of Perfluoroalkyl Acids in Wheat via a Split-Root Exposure Technique
Published on: September 28, 2022
Structure-related differences in plasma protein binding of per- and polyfluoroalkyl substances in mice and humans
Chloé Ml Argoul1, Pierre-Louis Toutain2, Sarah Berard3
1INTHERES, Université de Toulouse, INRAE, ENVT, Toulouse, France; ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France.
Abstract:
Understanding interspecies and structure-based differences in the toxicokinetics of perfluoroalkyl substances (PFAS) is important to explain their persistence and improve health risk assessment. Since renal clearance is the main elimination pathway, this study measured the free (protein-unbound) fraction (fu) of PFAS in human and mouse plasma using the DianormR system, selected for its robustness and rapid equilibrium. Sixteen PFAS were tested, including perfluoroalkyl carboxylic acids (PFCA), sulfonic acids (PFSA), and ether derivatives (PFECA). Mean fu values ranged from 0.21 % (PFOS) to 50 % (PFPeA) in mice and from 0.02 % (PFHpS) to 8.5 % (PFPeA) in humans. Interspecies differences were most pronounced for short-chain PFAS and PFECA, but not observed for longer chains. A U-shaped relationship between fu and molecular weight (MW) was found, with the lowest values near 400-500 g/mol. These results highlight plasma protein binding as a key determinant of PFAS persistence and provide predictive models linking fu to MW.
More Related Videos
09:04Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
Published on: April 18, 2019
11:11Determination of Plasma Membrane Partitioning for Peripherally-associated Proteins
Published on: June 15, 2018
Related Concept Videos
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Drug Distribution: Plasma Protein Binding
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Drug Distribution: Tissue Binding
For...